UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.

Universal Vision Biotechnology Co., Ltd.

3218

TW0003218004

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
240.5 ^TWD	-1.84%		-7.50%	-13.18%

Mar. 14	Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024	CI

Universal Vision Biotechnology Co., Ltd. Announce Audit Committee Appointment

August 27, 2021 at 06:42 am EDT

Universal Vision Biotechnology Co., Ltd. appointed Yun-Hua Yang to the Audit Committee. Effective date of the new member: August 27, 2021.

Latest news about Universal Vision Biotechnology Co., Ltd.

Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024	Mar. 13	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 12	CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023	23-08-10	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-16	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup	23-01-17	DJ
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes	22-10-20	CI
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer	22-08-12	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Universal Vision Biotechnology Co., Ltd. Announces Dividend, Payable on May 13, 2022	22-03-30	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Universal Vision Biotechnology Co., Ltd. Announce Audit Committee Appointment	21-08-27	CI
Universal Vision Biotechnology Co., Ltd. Announces Expiration for the 4Th Term of the Remuneration Committee of the Company	21-08-27	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-10	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend Payable on May 13, 2021	21-03-24	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-23	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
Universal Vision Biotechnology Co., Ltd.(GTSM:3218) added to S&P Global BMI Index	20-09-21	CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-11	CI

Chart Universal Vision Biotechnology Co., Ltd.

Duration

Period

Chart Universal Vision Biotechnology Co., Ltd.

More charts

UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Universal Vision Biotechnology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

245 TWD

Average target price

313.8 TWD

Spread / Average Target

+28.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-13.18%	636M
ESSILORLUXOTTICA	+11.45%	98.89B
ALCON INC.	+9.17%	39.29B
AUTEK CHINA INC.	-23.47%	2.14B
WARBY PARKER INC.	-9.86%	1.55B
PEGAVISION CORPORATION	+31.15%	1.16B
MENICON CO., LTD.	-35.29%	744M
MINGYUE OPTICAL LENS CO.,LTD.	-37.31%	730M
VIZIONFOCUS INC.	+24.44%	477M
VISCO VISION INC.	+16.59%	466M

Glasses, Spectacles & Contact Lenses